Fulltext

Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network

Kario K 1 , Park S 2 , Buranakitjaroen P 3 , Chia YC 4 , Chen CH 5 , Divinagracia R 6 Show all authors , Hoshide S 1 , Shin J 7 , Siddique S 8 , Sison J 9 , Soenarta AA 10 , Sogunuru GP 11 , Tay JC 12 , Turana Y 13 , Wong L 14 , Zhang Y 15 , Wang JG 16

Affiliations 

  • 1 Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
  • 2 Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea
  • 3 Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 4 Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia
  • 5 Department of Medicine, Faculty of Medicine National Yang-Ming University, Taipei, Taiwan
  • 6 University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines
  • 7 Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea
  • 8 Punjab Medical Center, Lahore, Pakistan
  • 9 Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines
  • 10 Department Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center Harapan Kita, Jakarta, Indonesia
  • 11 Apollo Hospitals, Chennai, India
  • 12 Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore
  • 13 Department of Neurology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
  • 14 Department of Medicine & Therapeutics, Division of Neurology, Chinese University of Hong Kong, Hong Kong
  • 15 Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 16 Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
J Clin Hypertens (Greenwich), 2018 03;20(3):456-461.
PMID: 29450979 DOI: 10.1111/jch.13216

Abstract

Hypertension is an important modifiable cardiovascular risk factor and a leading cause of death throughout Asia. Effective prevention and control of hypertension in the region remain a significant challenge despite the availability of several regional and international guidelines. Out-of-office measurement of blood pressure (BP), including home BP monitoring (HBPM), is an important hypertension management tool. Home BP is better than office BP for predicting cardiovascular risk and HBPM should be considered for all patients with office BP ≥ 130/85 mm Hg. It is important that HBPM is undertaken using a validated device and patients are educated about how to perform HBPM correctly. During antihypertensive therapy, monitoring of home BP control and variability is essential, especially in the morning. This is because HBPM can facilitate the choice of individualized optimal therapy. The evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for HBPM in Asia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications